We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Alphapharm has filed an application with the FDA challenging patents on Forest Laboratories’ antidepressant Lexapro (escitalopram oxalate), according to Forest.